Compliance to oral bisphosphonate therapy similar regardless of follow-up type
Compliance and persistence to oral bisphosphonate therapy following initiation within a secondary fracture prevention program: a randomised controlled trial of specialist vs. non-specialist managementOsteoporos Int. 2014 Apr;25(4):1345-55. doi: 10.1007/s00198-013-2610-4. Epub 2014 Jan 21.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
102 patients with incident osteoporotic fractures were initiated on oral bisphosphonate therapy within a secondary fracture prevention program with subsequent management by either a specialist (Group A) or a primary care physician (Group B). Compliance and persistence to oral bisphosphonate therapy was determined over 2 years. Compliance and persistence were high, and did not significantly differ ...
Join the Conversation
Please Login or Join to leave comments.